Dr. Talal Alharazi M.D.
Professor of Medical Parasitology, University of Ha'il ORCID:0000-0002-3371-0477 · Yemen
Editorial leadership for Journal of Biotechnology and Biomedical Science ISSN 2576-6694
Research interests
- Medical Parasitology Helminthology
- Neglected Tropical Diseases (Ntds) Infectious Disease Epidemiology (Hiv
- Hcv
- Hbv
- Malaria) Intestinal Parasitic Infections Computational Drug Screening (In Silico Pharmacology) Nanomedicine
- Nano-Therapeutics
Biography
Dr. Talal Alharazi is a highly experienced Professor specializing in Medical Parasitology and Infectious Disease Epidemiology. His scientific contributions focus on understanding the prevalence, risk factors, and distribution of parasitic diseases, including helminthology and neglected tropical diseases (NTDs), particularly in communities in Yemen and Saudi Arabia. Beyond traditional parasitology, his current research employs modern computational and nano-therapeutic approaches to combat global health issues like diabetes complications and cancer, demonstrating a commitment to translational public health solutions.
Professional Background
- Professor of Medical Parasitology (Current), Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Ha'il, Saudi Arabia.
- Assistant Professor/Faculty, Medical Microbiology and Immunology Department, Faculty of Medicine, Taiz University, Yemen.
Achievements
- Extensive publication record addressing critical public health issues related to infectious and parasitic diseases in the Middle East.
- Pioneering research integrating computational drug screening and nano-therapeutics into parasitology and infectious disease management.
Current Research Projects
Dr. Alharazi's current work is dual-focused, investigating both epidemiological trends of parasitic infections and developing novel therapeutics:
- Epidemiological studies on the prevalence, knowledge, attitude, and practices related to intestinal parasitic infections and cutaneous leishmaniasis in endemic areas.
- Computational drug discovery, focusing on identifying natural inhibitors (e.g., from Cynomorium songaricum) for key enzymes involved in diabetic complications (ALR2).
- Research into nanomedicine and nano-therapeutics for cancer treatment.
Academic Profiles of Dr. Talal Alharazi
Explore his academic and professional presence across trusted platforms.
Selected publications
- Knowledge and attitude towards cutaneous leishmaniasis among rural endemic communities in Shara’b district, Taiz, southwestern Yemen 2021 cited 33×
- Antimicrobial Potential of Pithecellobium dulce Seed Extract against Pathogenic Bacteria: In Silico and In Vitro Evaluation 2023 cited 28×
- Prevalence of Transfusion-Transmitted Infections (HCV, HIV, Syphilis and Malaria) in Blood Donors: A Large-Scale Cross-Sectional Study 2022 cited 23×
- Detection of Total Aflatoxins in Groundnut and Soybean Samples in Yemen Using Enzyme-Linked Immunosorbent Assay 2019 cited 13×
- Increasing Resistance of Nosocomial and Community-Acquired Escherichia coli in Clinical Samples from Hospitals and Clinics in Sana’a City 2024 cited 6×
- Identification and evaluation of putative type 2 diabetes mellitus inhibitors derived from Cichorium intybus 2024 cited 6×
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBBS for your work?
This journal is guided by Dr. Talal Alharazi (Professor of Medical Parasitology, University of Ha'il ORCID:0000-0002-3371-0477) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.